Suchergebnisse - "Kazandjian, Dickran"

PubPharm (13)

1

Minimal Residual Disease-Adapted Therapy in Multiple Myeloma : Current Evidence and Opinions

enthalten in: Current oncology reports | 2024

von Meseha, M. | Hoffman, J. | Kazandjian, D. | +2

2

T cell redirecting bispecific antibodies for multiple myeloma : emerging therapeutic strategies in a changing treatment landscape

enthalten in: Leukemia & lymphoma | 2022

von Kazandjian, D. | Kowalski, A. | Landgren, O.

3

Daratumumab : A review of current indications and future directions

enthalten in: Seminars in oncology | 2022

von Hill, E. | Morrison, C. | Kazandjian, D.

4

Current and prospective antibody-based therapies in multiple myeloma

enthalten in: Seminars in oncology | 2022

von Bryer, E. | DeStefano, C. | Kazandjian, D.

5

Managing multiple myeloma in a resource-limited region : Diagnosis and treatment in Armenia

enthalten in: Seminars in oncology | 2021

von Oganesyan, A. | Ghahramanyan, N. | Mekinian, A. | +3

6

Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

enthalten in: The oncologist | 2021

von Kazandjian, D. | Dew, A. | Hill, E. | +19

7

Second malignancies in multiple myeloma; emerging patterns and future directions

enthalten in: Best practice & research. Clinical haematology | 2020

von Maclachlan, K. | Diamond, B. | Maura, F. | +4

8

The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!

enthalten in: Best practice & research. Clinical haematology | 2020

von Kazandjian, D. | Dew, A. | Hill, E.

9

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Sissung, T. | Peer, C. | Korde, N. | +5

10

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

enthalten in: Cancer chemotherapy and pharmacology | 2017

von Sissung, T. | Peer, C. | Korde, N. | +5